Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rockledge, FL
NPI
1275513731
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
835 Executive Ln, Suite 110
Rockledge, FL, 32955
Phone (321) 638-2075
Groups this clinician bills Medicare through
Medicare paid, 2024
$377K
11,897 services
Medicare patients, 2024
875
Average age 74
Drug cost, 2024
$1.3M
2,844 prescriptions
Company payments, 2025
$2,047
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rita Jain was code J0897 (injection, denosumab, 1 mg), 7,860 times for 73 patients. In total Rita Jain billed 11,897 services in 15 codes, and Medicare paid $377K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,860 | 73 | $20.60 | $162K |
| 99214 Office E&M - Established | Office | 1,286 | 554 | $87.12 | $112K |
| 82962 Clinical Chemistry | Office | 796 | 349 | $3.14 | $2,503 |
| 99213 Office E&M - Established | Office | 592 | 381 | $60.02 | $36K |
| 95251 Test - Miscellaneous | Office | 440 | 168 | $24.68 | $11K |
| 83036 Blood Count | Office | 247 | 163 | $9.52 | $2,351 |
| 99442 Telephone Services | Office | 217 | 149 | $61.89 | $13K |
| 96401 Chemotherapy Administration | Office | 169 | 95 | $48.20 | $8,146 |
| 99443 Telephone Services | Office | 139 | 98 | $91.27 | $13K |
| 99204 Office E&M - New | Office | 122 | 122 | $123.91 | $15K |
| 99215 Office E&M - Established | Office | 15 | 15 | $133.73 | $2,006 |
By year: 2022 $337K for 10,802 services; 2023 $328K for 10,628 services; 2024 $377K for 11,897 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 796 | 349 | $3.14 | $2,503 |
| 83036 Blood Count | 247 | 163 | $9.52 | $2,351 |
Medicare prescription drug claims, 2024
In 2024, the drug Rita Jain prescribed most often to Medicare patients was Levothyroxine Sodium, with 521 prescriptions and refills. In total Rita Jain wrote 2,844 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 521 | 1,528 | 200 | $5,433 |
| Metformin Hcl Er Metformin Hcl | 290 | 809 | 113 | $2,943 |
| Synthroid Levothyroxine Sodium | 146 | 395 | 51 | $12K |
| Ozempic Semaglutide | 130 | 235 | 48 | $223K |
| Farxiga Dapagliflozin Propanediol | 73 | 130 | 18 | $66K |
| Methimazole Generic | 57 | 163 | 25 | $640 |
| Prolia Denosumab | 56 | 336 | 39 | $96K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 56 | 148 | 25 | $6,367 |
| Jardiance Empagliflozin | 56 | 144 | 24 | $84K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 54 | 149 | 21 | $86K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 50 | 109 | 17 | $8,371 |
| Mounjaro Tirzepatide | 50 | 74 | 17 | $77K |
| Atorvastatin Calcium Generic | 48 | 141 | 19 | $495 |
| Trulicity Dulaglutide | 45 | 76 | 20 | $73K |
| Metformin Hcl Generic | 45 | 131 | 15 | $482 |
Brand drugs: 1,657 claims; generic drugs: 1,011 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rita Jain $2,047 ($2,047 in general payments such as food, travel and fees) from 23 companies. The largest payer was Amgen Inc. with $289.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 9 | $289 |
| Radius Health, Inc. | 9 | $242 |
| Lilly USA, LLC LLY | 5 | $199 |
| Abbott Laboratories ABT | 9 | $199 |
| Corcept Therapeutics CORT | 12 | $197 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $124 |
| Abbvie Inc. ABBV | 6 | $122 |
| Novo Nordisk Inc NVO | 6 | $96.32 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $74.79 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $70.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.